Itron Invites Nominations for 2024 Innovator Award
July 23, 2024 08:45 ET
|
Itron, Inc.
Award recognizes Itron customers for implementing cutting-edge solutions with Itron’s partner program
Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 2024
July 22, 2024 08:00 ET
|
Oxford BioTherapeutics
Oxford, UK and San Jose, California, 22 July 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...
Santiago Calatrava and John Zils to Receive 2024 Lifetime Achievement Awards from Council on Tall Buildings and Urban Habitat
July 18, 2024 11:00 ET
|
The Council on Tall Buildings and Urban Habitat
Chicago, July 18, 2024 (GLOBE NEWSWIRE) -- The Council on Tall Buildings and Urban Habitat (CTBUH) today announced the winner of its 2024 Lynn S. Beedle Lifetime Achievement Award: Santiago...
Itron Celebrates More Than 1 Million Cyble™ 5 Communication Modules Shipped
July 18, 2024 08:45 ET
|
Itron, Inc.
Severn Trent Water receives milestone module as part of project to improve consumer engagement and improve leak detection.
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
July 18, 2024 03:05 ET
|
Boehringer Ingelheim
Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosisStrong first half net sales...
Novartis erzielt im zweiten Quartal weiterhin kräftige Umsatzsteigerungen und erhöht die Kerngewinnmarge; Gewinnprognose für das Geschäftsjahr 2024 angehoben
July 18, 2024 01:00 ET
|
Novartis Pharma AG
Ad-hoc-Mitteilung gemäss Art. 53 KRDer Nettoumsatz wuchs im zweiten Quartal um +11% (kWk1, +9% USD), das operative Kernergebnis verbesserte sich um +19% (kWk, +17% USD) Das Umsatzwachstum...
Novartis a poursuivi au T2 la forte croissance de son chiffre d’affaires et l’expansion de sa marge core; hausse des prévisions de son résultat opérationnel core pour 2024
July 18, 2024 01:00 ET
|
Novartis Pharma AG
Annonce événementielle au sens de l’art. 53 RCRésultats du deuxième trimestre (T2)Chiffre d’affaires net en hausse de +11% (tcc1, +9% USD) et du résultat opérationnel core, de +19% (tcc, +17% USD) La...
Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance
July 18, 2024 01:00 ET
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto...
Une nouvelle publication dans Nature confirme l’avance de CARBIOS dans la dégradation enzymatique du plastique
July 17, 2024 12:00 ET
|
Carbios
CARBIOS et Toulouse Biotechnology Institute (TBI) publient un article présentant les travaux d'optimisation enzymatique permettant à un PLA enzymé de se désintégrer et de se biodégrader dans des...
New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic
July 17, 2024 12:00 ET
|
Carbios
CARBIOS and Toulouse Biotechnology Institute (TBI) publish groundbreaking article that presents enzyme optimization work leading to an enzyme-embedded PLA able to disintegrate and biodegrade in...